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Introduction
Inflammation in the central nervous system (CNS), whether of infectious or autoimmune etiology, is associated with infiltration of immune cells into the cerebrospinal fluid (CSF) and brain parenchyma. This infiltration has been described to occur via three distinct routes of entry: 1. from the blood to CSF across the choroid plexus, 2. from blood to the subarachnoid space, and 3. from blood to parenchymal perivascular space (Ransohoff et al., 2003) . Harvesting the CSF by lumbar puncture is valuable both for refining a differential diagnosis and for investigating the etiology of various diseases. The chemokine receptor profile and activation kinetics of immune cells infiltrating the subarachnoid space may offer a window into the pathogenic effects of these cells by highlighting their migratory and effector functions.
During inflammation, activated cells are known to preferentially enter the CNS via a process involving selectins, chemokines, chemokine receptors, and cell adhesion molecules (Wekerle et al., 1986; Hickey, 1991; Hickey et al., 1991; Springer, 1994) . These cells are not necessarily antigen-specific, although antigen-specific cells have been located in the CNS (Hafler and Weiner, 1987; Olsson et al., 1990) . It is not known, however, whether the cells in the CSF of a patient with an autoimmune disease such as multiple sclerosis (MS) represent a select subset of effector cells already primed to cause damage to the CNS, or if local conditions within the perivascular space or brain parenchyma in MS induce , 1999a, 1999b) . CCR7 has been shown to be highly expressed on CSF cells, while cells within MS brain lesions have a CCR7 − effector phenotype (Giunti et al., 2003; Kivisakk et al., 2003a Kivisakk et al., , 2003b Kivisakk et al., , 2004 Rus et al., 2005) . Previous studies have used markers such as CD25, CD26, and CD29, and chemokine receptors such as CXCR3 to differentiate between active and quiescent stages of MS (Kraus et al., 2000a (Kraus et al., , 2000b Sindern et al., 2002; Matsui et al., 2004; Okuda et al., 2005) . Herein, we demonstrate that CSF cells from a variety of inflammatory and non-inflammatory diseases are more likely to be T EM than peripheral blood cells, both immediately ex vivo and after T cell stimulation with anti-CD3 and anti-CD28 antibodies. CSF cells from inflammatory disease processes tend to have a higher percentage of T EM cells and fewer T CM Journal of Neuroimmunology 249 (2012) [86] [87] [88] [89] [90] [91] [92] 
